Visión generalGráficoPerfilEstadísticas claveBalance generalTécnicoNoticias
Derivados
TraderScreen

RWE AG INH O.N./  DE0007037129  /

gettex
09/05/2024  13:21:22 Diferencia +0.380 Volumen Bid13:23:08 Ask13:23:08 Capitalización de mecado Dividendo A. P/E Ratio
33.420EUR +1.15% 25,317
Volumen de negocios: 840,939.940		 33.400Volumen de oferta: 1,796 33.410Tamaño/ Volumen/ Formato de Ask: 1,796 24.68 mil millonesEUR 3.01% 17.02
GlobeNewswire 13:20 Vital Farms Reports First Quarter 2024 Financial Results
GlobeNewswire 13:19 Kingsoft Cloud to Report First Quarter 2024 Financial Results on May 22, 2024
GlobeNewswire 13:15 Verona Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire 13:15 ADC Therapeutics to Participate in 2024 RBC Capital Markets Global Healthcare Conference
TeleTrader 13:10 WBD's Q1 revenue down by 7% to $9.9 billion
TeleTrader 13:05 10 injured as Boeing 737 slid off runway in Senegal
GlobeNewswire 13:04 Standard Lithium Reports Fiscal Third Quarter 2024 Results, Schedules Investor Update Call
GlobeNewswire 13:02 Xometry Reports First Quarter 2024 Results
GlobeNewswire 13:01 Nevada Copper Files Financial Statements and MD&A for the Quarter Ended March 31, 2024
GlobeNewswire 13:01 Prelude Therapeutics to Participate in Citizens JMP Life Sciences Conference
GlobeNewswire 13:01 HOOKIPA Pharma Reports First Quarter 2024 Financial Results and Recent Business Highlights
GlobeNewswire 13:00 Tower Semiconductor Reports 2024 First Quarter Financial Results
GlobeNewswire 13:00 Allegro MicroSystems Reports Fourth Quarter and Fiscal Year 2024 Results
GlobeNewswire 13:00 Renalytix to Report Financial Results for Third Quarter Fiscal Year 2024 on May 15
TeleTrader 13:00 BoE keeps its interest rate at 5.25% again
GlobeNewswire 13:00 Lifetime Brands, Inc. Reports First Quarter 2024 Financial Results
GlobeNewswire 13:00 Wave Life Sciences Announces Appointment of Dr. Erik Ingelsson as Chief Scientific Officer
GlobeNewswire 13:00 BioXcel Therapeutics Reports First Quarter 2024 Financial Results
GlobeNewswire 13:00 Monte Rosa Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire 13:00 Lantronix to Participate in the 19th Annual Needham Technology, Media, & Consumer Investor Conferenc...
GlobeNewswire 13:00 First Wave BioPharma and Celiac Journey to Host Nasdaq Event in Support of Celiac Disease Awareness ...
GlobeNewswire 13:00 NOWPayments Enables Cryptocurrency Purchases of Tangem Wallets: Expanding Payment Options with BTC, ...
GlobeNewswire 13:00 Alector to Participate in Upcoming Healthcare Conferences
GlobeNewswire 13:00 Verona Pharma Announces $650 Million Strategic Financing with Oaktree and OMERS
GlobeNewswire 13:00 Royalty Pharma Reports First Quarter 2024 Results